Ergomed takes on former Shire man in finance role
Stephen Stamp was group finance director at serviced office group Regus and finance director at pharma major Shire in previous jobs.
Company
Ergomed PLC
LON:ERGO
Ergomed PLC provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. The company's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO).
204 stories · page 10 of 11
Investments and investor services
Proactive news highlights: MX Oil, W Resources, Alecto Minerals, Metal Tiger and more...
African Potash, Sound Energy and Tungsten Corp also had news out on Wednesday
Archive
Proactive small cap news highlights - Asiamet, Metminco, Trinity Exploration, Sound Energy, SacOil, Oilex, Photo-Me, Globo & others
Asiamet saw a resource upgrade, Metminco got a boost in its partnering efforts and Sound Energy's teamed up with Schlumberger
UPDATE - Ergomed unfazed by cancer trial end
It will not invest or participate in four other ongoing studies for the compound.
Investments and investor services
Proactive news highlights including Gfinity, Cohort, Motif Bio, Ergomed, Tern, dotDigital and more
A number of tech and mining companies had news out today
Ergomed says sickle-cell drug enters proof-of-concept study
Ergomed’s partner, the Swedish firm Dilaforette, is hoping to recruit 70 sufferers that can be evaluated using the drug, which is called sevuparin.
Investments and investor services
Proactive news highlights including Fastjet, Active energy, KEFI, Arian Silver...
There was a lot of news from the small cap space today
Ergomed increases backing for Multikine cancer treatment
Multikine is designed to be a different type of therapy in the fight against cancer: one that appears to have the potential to work with the body's natural immune system in the fight against tumours.
Archive
Proactive (non-mining) news summary: Active Energy, Aggregated Micro, Globo, Learning Technologies .
The end of quarter is approaching so companies were rushing out end-June trading updates, leading to a very heavy news day.
UPDATE - Ergomed orders grow strongly as it weighs in with solid set of interims
As well as providing clinical services, the company is partnered on a number of drug candidates.
Investments and investor services
Tuesday's agenda: Wolseley to highlight strength of US economy
Wolseley and Boohoo.com lead the companies reporting on Tuesday...
Archive
Week Ahead: Sainsbury's to update on the trolley wars
Sainsbury is likely to report continued hard times for the grocers.
Investments and investor services
Proactive news highlights: Velocys, Globo, eg Solutions, Gemfields, Ergomed, Kibo Mining and more...
Oil and mining dominated the small cap headlines today
Ergomed named finalist at Scrip awards
Ergomed, which provides drug development services to the pharma sector, says its successful run is continuing with the firm being shortlisted for a leading industry award.
Four Exciting Companies to present in London on Thursday 17th September
The management from e-Therapeutics (LON:ETX), Ergomed (LON:ERGO), Tissue Regenix (LON:TRX) and TekCapital (LON:TEK) will be updating investors on current developments and future prospects.
Friday’s news highlights Ergomed, Avation, Mytrah, Tekcapital, Armadale, Rosslyn Data Technologies, ZincOx, Stellar Diamonds
Ergomed said a cancer drug it helped developed will undergo a second-round efficacy and safety assessment
Ergomed announces first patient has been recruited for insomnia study
The study is a Phase IIa clinical trial testing the efficacy, safety and tolerability profile of Lorediplon in adult patients with insomnia disorder.
Ergomed appoints familiar face as chief business officer
Ergomed's newly appointed executive director has been working as a consultant for the company for the last 10 year.
Ergomed says patient recruitment is complete for womb cancer study
"We believe that zoptarelin doxorubicin has the potential to provide a new treatment for women with endometrial cancer, and look forward to obtaining data and progressing this study with our co-development partner Aeterna Zentaris, " said M
Archive
Proactive news summary: Xtract Resources, Wolf Minerals, ValiRx, Trap Oil, Sula Iron & Gold ...
Lekoil was boosted by the chief executive topping up his holding but there was some grim news elsewhere from the oil sector.